Stockreport

Ionis and partner announce enrollment completion of global Phase 3 GENERATION HD1 study for Huntington's disease

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com